(Q35007647)

5 August 2017

title

Treatment with the 5-HT3 antagonist tropisetron modulates glucose-induced obesity in mice (English)

1 reference

5 August 2017

0 references

0 references

S Weber

1

1 reference

5 August 2017

V Volynets

2

1 reference

5 August 2017

G Kanuri

3

1 reference

5 August 2017

I Bergheim

4

1 reference

5 August 2017

S C Bischoff

5

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

International Journal of Obesity

5 August 2017

published in

1 reference

5 August 2017

volume

33

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

1339-1347

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2009.191

5 August 2017

exact match

0 references

cites work

Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

Clinical and laboratory diagnosis of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Dietary management of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Effects of fructose and glucose preloads on subsequent food intake

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Long-term sucrose and glucose consumption decreases the delta-aminolevulinate dehydratase activity in mice.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Effects of sucrose, glucose and fructose on peripheral and central appetite signals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Carbohydrate-induced hyperphagia and obesity in the rat: effects of saccharide type, form, and taste

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Serotonergic influences on food intake: effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Effects of peripheral administration of 5-hydroxytryptamine (5-HT ) on 2-deoxy-D-glucose-induced hyperphagia in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Intestinal nutrients elicit satiation through concomitant activation of CCK(1) and 5-HT(3) receptors

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Liquid calories, sugar, and body weight

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Differential effects of sucrose, fructose and glucose on carbohydrate-induced obesity in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Sucrose and polysaccharide induced obesity in the rat

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Serotonergic drugs : effects on appetite expression and use for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Sucrase-isomaltase and hexose transporter gene expressions are coordinately enhanced by dietary fructose in rat jejunum

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.191

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.191

1 reference

5 August 2017

1 reference